Corporate Actions and Equity Markets
Movano merger faces regulatory hurdle as SEC review delays Corvex all-stock deal
ViaNews Editorial Team (Markets)•
#regulatory approval
2 articles
Pharmaceutical Stocks
Exeltis Faces Regulatory Cliff on Tafoxiparin Deal as Approval Failure Looms
ViaNews Editorial Team (Markets)•